CASE-STUDY: Advancing Pediatric Clinical Trials Overcoming Challenges in the Clinical Trial of Pegfilgrastim for Rhabdomyosarcoma & Wilms' Tumor Advancing Pediatric Clinical Trials – Overcoming Challenges in the Clinical Trial of Pegfilgrastim Post author:Dipesh Chodvadia Post published:November 30, 2023 Post category:Case-Study Tags: Case-Study Read more articles Previous PostAccelerating Patient Recruitment: Atopic Dermatitis Trials | Topical Tacrolimus Next PostAdvancing Breast Cancer Research – Lambda and Novum’s Commitment to Patient-Centric Trials You Might Also Like Overcoming challenges in a Patient-based PK study (Paliperidone) held during the COVID-19 pandemic November 30, 2023 From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar June 9, 2026 Multicentre Paediatric Acceptability Study for Cyclophosphamide Powder June 9, 2026
Overcoming challenges in a Patient-based PK study (Paliperidone) held during the COVID-19 pandemic November 30, 2023
From Study Execution to EMA Success A Global Phase III Program for Ranibizumab – Ophthalmic Biosimilar June 9, 2026
